Given the association of MHC-I with synaptic pruning, learning, and memory [89, 90], future investigations should aim to clarify whether SCD1 inhibition offers protection in late-stage AD by modulating MHC-I signaling in microglia. The gene discussed is SCD; the disease is Alzheimer disease.